Error: Could not add to watchlist. X

Oasmia Pharmaceutical AB

+ Watchlist
OMAX:GR
Frankfurt
1.81
EUR
0.03
1.69%
As of 09:40:27 ET on 08/28/2015.
Open
1.75
Day Range
1.75 - 1.82
Volume
1,000
Previous Close
1.78
52Wk Range
1.60 - 2.43
1 Yr Return
-21.17%
Open
1.75
Day Range
1.75 - 1.82
Volume
1,000
Previous Close
1.78
52Wk Range
1.60 - 2.43
1 Yr Return
-21.17%
YTD Return
-12.23%
Current P/E Ratio (TTM)
-
Earnings per Share (SEK) (TTM)
-
Market Cap (m EUR)
177.025
Shares Outstanding (m)
97.858
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Oasmia Pharmaceutical AB operates as a pharmaceutical company. The Company focuses on treatments within human and animal oncology. Oasmia Pharmaceutical develops and markets chemotherapeutic drugs that can be used for the treatment of cancer in both humans and companion animals.
ADDRESS
Vallongatan 1
Uppsala, 752 28
Sweden
PHONE
46-18-50-54-40
  • Julian Aleksov
    Chairman/President/Co-Founder
  • Mikael Asp
    Chief Executive Officer
  • Anders Blom
    Exec Vice President
  • Margareta Eriksson
    VP:Clinical Development
  • Ingela Hagglund
    VP:Operations
Show More